Borja J - Search Results

1

Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.

Valero A, de la Torre F, Castillo JA, Rivas P, del Cuvillo A, Antépara I, Borja J, Donado E, Molà O, Izquierdo I. Valero A, et al. Among authors: borja j. Drug Saf. 2009;32(1):33-42. doi: 10.2165/00002018-200932010-00003. Drug Saf. 2009. PMID: 19132803 Clinical Trial.

2

Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.

Antonijoan RM, Gich I, Azaro A, Sainz S, Balanzó J, Izquierdo I, Borja J, Donado E, Blanch I, Barbanoj MJ. Antonijoan RM, et al. Among authors: borja j. Eur J Clin Pharmacol. 2011 Jul;67(7):663-9. doi: 10.1007/s00228-011-1004-9. Epub 2011 Feb 16. Eur J Clin Pharmacol. 2011. PMID: 21327422 Clinical Trial.

3

Antithrombotic treatment in atrial fibrillation. Response to: Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC: the risks of warfarin use in the elderly. Expert Opin. Drug Saf. (2006) 5(3):417-431.

Borja J, García O, Izquierdo I. Borja J, et al. Expert Opin Drug Saf. 2006 Jul;5(4):485-6. doi: 10.1517/14740338.5.4.485. Expert Opin Drug Saf. 2006. PMID: 16774485 No abstract available.

4

Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study.

Izquierdo I, Borja J, Rovira S, Pelagio P, Torres F, Cebrecos J, García-Rafanell J. Izquierdo I, et al. Among authors: borja j. Arzneimittelforschung. 2010;60(1):36-41. doi: 10.1055/s-0031-1296246. Arzneimittelforschung. 2010. PMID: 20184225 Clinical Trial.

5

Evaluation of the methodological quality of clinical trial protocols. A preliminary experience in Spain.

García-Cases C, Duque A, Borja J, Izquierdo I, de la Fuente V, Torrent J, Jané F. García-Cases C, et al. Among authors: borja j. Eur J Clin Pharmacol. 1993;44(4):401-2. doi: 10.1007/BF00316482. Eur J Clin Pharmacol. 1993. PMID: 8513855

6

Clopidogrel and metoprolol in myocardial infarction.

Borja J, García O, Donado E, Izquierdo I. Borja J, et al. Lancet. 2006 Mar 11;367(9513):811-2. doi: 10.1016/S0140-6736(06)68327-X. Lancet. 2006. PMID: 16530566 No abstract available.

7

Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva.

Obach R, Borja J, Pruñonosa J, Vallès JM, Torrent J, Izquierdo I, Jané F. Obach R, et al. Among authors: borja j. Ther Drug Monit. 1988;10(3):265-8. doi: 10.1097/00007691-198803000-00004. Ther Drug Monit. 1988. PMID: 3176100

8

COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study.

Miravitlles M, Izquierdo I, Herrejón A, Torres JV, Baró E, Borja J; ESFERA investigators. Miravitlles M, et al. Among authors: borja j. Respir Med. 2011 May;105(5):740-7. doi: 10.1016/j.rmed.2010.12.020. Epub 2011 Jan 12. Respir Med. 2011. PMID: 21227672 Free article.

9

Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky.

Borja J, Izquierdo I, Guindo J. Borja J, et al. BMJ. 2006 Jul 8;333(7558):97. doi: 10.1136/bmj.333.7558.97. BMJ. 2006. PMID: 16825239 Free PMC article. No abstract available.

10

Prevention of stroke in patients with ischemic stroke or transient ischemic attack.

Borja J, Izquierdo I, García-Rafanell J. Borja J, et al. Stroke. 2006 Nov;37(11):2653; author reply 2654. doi: 10.1161/01.STR.0000244549.87017.13. Epub 2006 Sep 14. Stroke. 2006. PMID: 16973925 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters